These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD Nagata N; Masuko S; Inoue R; Nakamura T; Aritake K; Murata T J Immunol Res; 2021; 2021():5591115. PubMed ID: 33997056 [TBL] [Abstract][Full Text] [Related]
8. Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect. Shinozawa T; Urade Y; Maruyama T; Watabe D Biochem Biophys Res Commun; 2011 Dec; 415(4):539-44. PubMed ID: 22027143 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of a Human Urinary Metabolite of Prostaglandin D Kimbrough JR; Austin Z; Milne GL; Sulikowski GA Org Lett; 2019 Dec; 21(24):10048-10051. PubMed ID: 31799855 [TBL] [Abstract][Full Text] [Related]
10. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. Nakagawa T; Takeuchi A; Kakiuchi R; Lee T; Yagi M; Awano H; Iijima K; Takeshima Y; Urade Y; Matsuo M Clin Chim Acta; 2013 Aug; 423():10-4. PubMed ID: 23603101 [TBL] [Abstract][Full Text] [Related]
11. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Gielicz A; Pietrzyk JJ J Investig Allergol Clin Immunol; 2011; 21(4):260-9. PubMed ID: 21721371 [TBL] [Abstract][Full Text] [Related]
12. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. Higashi N; Taniguchi M; Mita H; Yamaguchi H; Ono E; Akiyama K Allergol Int; 2012 Sep; 61(3):393-403. PubMed ID: 22627848 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers. Zhang Y; Zhang G; Clarke PA; Huang JT; Takahashi E; Muirhead D; Steenwyk RC; Lin Z J Mass Spectrom; 2011 Jul; 46(7):705-11. PubMed ID: 21706677 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis. Cho C; Nguyen A; Bryant KJ; O'Neill SG; McNeil HP Immun Inflamm Dis; 2016 Mar; 4(1):64-9. PubMed ID: 27042302 [TBL] [Abstract][Full Text] [Related]
15. Dissociation between biological and clinical response to oral challenge in children with food allergy. Zanconato S; Carraro S; Gottardi G; Rusalen F; Alinovi R; Corradi M; Baraldi E Allergy; 2008 Oct; 63(10):1408-10. PubMed ID: 18782122 [No Abstract] [Full Text] [Related]
16. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine. Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890 [TBL] [Abstract][Full Text] [Related]
17. [The role of prostaglandin D Nakamura T Nihon Yakurigaku Zasshi; 2020; 155(6):386-389. PubMed ID: 33132255 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and therapy of food allergy. Crespo JF; James JM; Rodriguez J Mol Nutr Food Res; 2004 Oct; 48(5):347-55. PubMed ID: 15672474 [TBL] [Abstract][Full Text] [Related]
20. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. Awad JA; Morrow JD; Roberts LJ J Allergy Clin Immunol; 1994 May; 93(5):817-24. PubMed ID: 8182221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]